Abstract
The present technology relates to a method of treating one or more behavioral symptoms of autism spectrum disorder (ASD) in a subject by transdermally administering an effective amount of cannabidiol (CBD) to the subject wherein one or more behavioral symptoms of ASD are treated in the subject.
Full Text
What is claimed is:
The present technology relates to a method of treating one or more behavioral symptoms of autism spectrum disorder (ASD) in a subject by transdermally administering an effective amount of cannabidiol (CBD) to the subject wherein one or more behavioral symptoms of ASD are treated in the subject.
Timeline
Filed
02/27/2026Published
07/02/2026Granted
Not AvailableIPC Codes(5)
A61K 31/00:Medicinal preparations containing organic active ingredients
A61K 9/70:Web, sheet or filament bases
A61K 31/05:Phenols